Cormorant Asset Management, LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$4.5T
Holdings
119
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (119 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 400,000 | $3.5B | 0.08% | |
| 102 | —KADMON HLDGS INC | 750,000 | $2.9B | 0.07% | |
| 103 | ALLKGUSDALLAKOS INC | 25,000 | $2.9B | 0.06% | |
| 104 | NUVBNUVATION BIO INC | 234,445 | $2.5B | 0.05% | |
| 105 | AUTLAUTOLUS THERAPEUTICS PLC | 422,167 | $2.4B | 0.05% | |
| 106 | KNSAKINIKSA PHARMACEUTICALS LTD | 130,000 | $2.4B | 0.05% | |
| 107 | 1T7TRICIDA INC | 427,975 | $2.3B | 0.05% | |
| 108 | GRCLGRACELL BIOTECHNOLOGIES INC | 125,000 | $1.9B | 0.04% | |
| 109 | ORTXUSDORCHARD THERAPEUTICS PLC | 256,649 | $1.9B | 0.04% | |
| 110 | CRDFCARDIFF ONCOLOGY INC | 150,000 | $1.4B | 0.03% | |
| 111 | ARNAEURARENA PHARMACEUTICALS INC | 20,000 | $1.4B | 0.03% | |
| 112 | ASNSUSDX4 PHARMACEUTICALS INC | 103,980 | $895.0M | 0.02% | |
| 113 | FATEFATE THERAPEUTICS INC | 10,000 | $824.0M | 0.02% | |
| 114 | IMV1EURIMV INC | 234,374 | $772.0M | 0.02% | |
| 115 | NERVGBPMINERVA NEUROSCIENCES INC | 200,000 | $584.0M | 0.01% | |
| 116 | —CEREVEL THERAPEUTICS HLDNG I | 133,331 | $563.0M | 0.01% | |
| 117 | —OUTLOOK THERAPEUTICS INC | 416,666 | $421.0M | 0.01% | |
| 118 | NKTREURNEKTAR THERAPEUTICS | 20,000 | $400.0M | 0.01% | |
| 119 | NUVB/WSNUVATION BIO INC | 83,332 | $222.0M | 0.00% |
PreviousPage 2 of 2